Concepedia

Ling Zhou

LZ

Statistics

Publications

11

Citations

644

H-Index

11

Active since

2018

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Huazhong University of Science and Technology

St. John Hospital & Medical Center

Union Hospital

Ling Zhou is an author at Zhongnan Hospital of Wuhan University specializing in medicine, oncology, and thyroid cancer.

ORCID

Publications per year

2018–2023

11

Publications

11

Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension

Guang Yang, Zihu Tan, Ling Zhou et al. · Hypertension · 2020 · 313 citations

, , +17

Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19

Li Ni, Ling Zhou, Min Zhou et al. · Frontiers of Medicine · 2020 · 127 citations · Full text

, , +6

Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension

Guang Yang, Zihu Tan, Ling Zhou et al. · medRxiv · 2020 · 54 citations · Full text

, , +17

Factors associated with distant metastasis in pediatric thyroid cancer: evaluation of the SEER database

Zeming Liu, Di Hu, Yihui Huang et al. · Endocrine Connections · 2019 · 26 citations · Full text

, , +15

Minimal extrathyroidal extension affects the prognosis of differentiated thyroid cancer: Is there a need for change in the AJCC classification system?

Zeming Liu, Yihui Huang, Sichao Chen et al. · PLoS ONE · 2019 · 26 citations · Full text

, , +17

1–5 of 11